, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 166.78 %

Allergan, Inc. (AGN) rated Buy with price target $130 by Citigroup

Posted on: Tuesday,  Feb 4, 2014  8:25 AM ET by Citigroup

Citigroup rated Buy Allergan, Inc. (NYSE: AGN) on 02/04/2014, when the stock price was $114.69. Since
then, Allergan, Inc. has gained 166.79% as of 11/24/2015's recent price of $305.98.
If you would have followed this Citigroup's recommendation on AGN, you would have gained 166.78% of your investment in 658 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/4/2014 8:25 AM Buy
114.69 130.00
as of 10/17/2014
1 Week down  -5.39 %
1 Month up  4.38 %
3 Months up  7.03 %
1 YTD up  59.78 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/30/2012 8:25 AM Buy
7/20/2009 8:25 AM Buy
49.20 57.00
7/18/2008 8:25 AM Hold
52.09 54.00
7/18/2008 8:25 AM Hold
5/12/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy